A previous study showed that Neu5Ac can be targeted using a glycomimetic P-3Fax-Neu5Ac to inhibit metastatic spread of melanoma.26 Because our results showed that Neu5Ac was necessary to facilitate ovarian cancer growth, we investigated the ability of the previously described Neu5Ac-blocking glycomimetic P-3Fax-Neu5Ac to block IL-6 and IL-8 expression and inhibit ovarian cancer tumor cell growth. Here, CXCL8 is linked to melanoma.